Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Disease crawled time : 12:15 save search
Anavex Life Sciences Announces Participation at Upcoming Lausanne VIII Workshop Panel - Building Global Momentum for Interventions in Alzheimer’s Disease
Published: 2021-11-10 (Crawled : 12:15) - globenewswire.com
AVXL | $3.45 -6.25% 700K
|
Health Technology
|
| O: -7.28%
H: 3.35%
C: -1.43%
disease alzheimer life science anavex alzheimer’s alzheimer's disease alzheimer's
UNITY Biotechnology Announces Improvement in Visual Acuity Sustained Through 24 Weeks Following Single Dose of UBX1325 in Phase 1 Study of Patients with Advanced Vascular Eye Disease
Published: 2021-11-09 (Crawled : 12:15) - globenewswire.com
UBX | $1.46 -2.01% 62K
|
Health Technology
|
| O: -0.43%
H: 0.0%
C: 0.0%
disease eye phase 1 eye disease biotech ubx1325
Alterity Therapeutics Announces New Publications Providing Further Evidence of the Potential of ATH434 to Treat Neurodegenerative Diseases
Published: 2021-11-04 (Crawled : 12:15) - biospace.com/
ATHE | $2.39 12.21% 97K
|
Health Technology
|
| O: 1.61%
H: 5.56%
C: 0.0%
disease neurodegenerative potential ath434
Bristol Myers Squibb Data at ACR Convergence 2021 Illustrate Scientific Advances for Immune-Mediated Rheumatic Diseases
Published: 2021-11-03 (Crawled : 12:15) - biospace.com/
BMY | $48.76 -0.47% 3.9M
|
Health Technology
|
| O: -0.46%
H: 0.0%
C: 0.0%
disease media
Biogen Announces Late Breakers and Additional New Data Presentations at the 2021 Clinical Trials on Alzheimer’s Disease (CTAD) Meeting
Published: 2021-11-03 (Crawled : 12:15) - biospace.com/
BIIB | $202.7 4.93% 1.6M
|
Health Technology
|
| O: -0.21%
H: 3.05%
C: 2.97%
presentation disease alzheimer clinical trials trials trial alzheimer’s alzheimer's disease alzheimer's
Allena Pharmaceuticals Receives Fast Track Designation from FDA for the Development of ALLN-346 for Chronic Treatment of Hyperuricemia in Patients With Gout and Advanced Chronic Kidney Disease
Published: 2021-11-03 (Crawled : 12:15) - globenewswire.com
ALNA | $0.075 -12.0%
|
Health Technology
|
| O: 22.35%
H: 12.5%
C: -3.85%
disease treatment fda fast track fast track designation kidney designation
New Analyses Suggest Favorable Results for STELARA® (ustekinumab) When Used as a First-Line Therapy for Bio-Naïve Patients with Moderately to Severely Active Crohn's Disease and Ulcerative Colitis
Published: 2021-10-25 (Crawled : 12:15) - prnewswire.com
JNJ | News | $148.22 -0.9% 3.3M
|
Health Technology
|
| O: 0.32%
H: 0.36%
C: 0.22%
disease therapy results ulcerative colitis
RAPT Therapeutics Announces Upcoming Oral Presentation of RPT193 Phase 1b Data at the 4th Inflammatory Skin Disease Summit
Published: 2021-10-18 (Crawled : 12:15) - globenewswire.com
RAPT | $7.87 -1.63% 130K
|
Health Technology
|
| O: 2.9%
H: 0.94%
C: -4.57%
presentation disease phase 1 skin phase 1b phase 2b
Tonix Pharmaceuticals Announces Ribbon-Cutting Ceremony for its Infectious Disease R&D Center in Maryland
Published: 2021-10-15 (Crawled : 12:15) - globenewswire.com
TNXP | $0.159 1.4% 600K
|
Health Technology
|
| O: 2.02%
H: 2.62%
C: 1.77%
disease infectious disease
Bionano Genomics Announces American Society of Human Genetics Presentations Featuring Optical Genome Mapping for Genetic Disease and Cancer Research Applications
Published: 2021-10-15 (Crawled : 12:15) - globenewswire.com
BNGO | $0.7834 -1.39% 440K
|
Health Technology
|
| O: 1.31%
H: 0.18%
C: -4.62%
presentation disease genetic optical application genomic cancer research
Bio-Techne Announces ExoDx Prostate Test Data Publication in the Journal of Prostate Cancer and Prostatic Diseases
Published: 2021-10-13 (Crawled : 12:15) - biospace.com/
TECH | $62.87 -1.29% 350K
|
Health Technology
|
| O: 0.91%
H: 0.19%
C: 0.13%
disease prostate cancer test cancer
Inhibikase Therapeutics Announces Interim Three-month Results from Chronic Toxicology Studies of its Oral c-Abl Kinase Inhibitor, IkT-148009, in Development for Treatment of Parkinson's Disease
Published: 2021-10-04 (Crawled : 12:15) - prnewswire.com
IKT | $1.64 3.8% 23K
|
Health Technology
|
| O: 2.32%
H: 2.77%
C: -1.77%
disease treatment results parkinson ikt-148009
Larimar Therapeutics to Participate in SVB Leerink CybeRx Series: Neuromuscular, Rare Diseases & Genetic Medicines Event
Published: 2021-09-16 (Crawled : 12:15) - globenewswire.com
LRMR | $6.4 -0.93% 56K
|
Health Technology
|
| O: 2.41%
H: 0.31%
C: -9.65%
disease genetic rare
AGTC to Participate in Clinical Trials in Rare Diseases Conference Panel and Case Study
Published: 2021-09-09 (Crawled : 12:15) - agtc.com
OTIC | $0.077
|
Health Technology
|
| O: 0.0%
H: 1.33%
C: -0.67%
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: 1.49%
H: 2.35%
C: -0.29%
disease clinical trials trials trial conference rare
Brickell Biotech Acquires Exclusive Rights to Phase 1-Ready DYRK1A Inhibitor Program and Novel Platform Targeting Autoimmune and Inflammatory Diseases
Published: 2021-09-01 (Crawled : 12:15) - biospace.com/
BBI | $2.12 16.04%
|
Health Technology
|
| O: 0.2%
H: 1.35%
C: 1.22%
disease phase 1 biotech iot phase 2 phase 3
Data from NIH/NHLBI-Sponsored Phase 2 Trial of Fostamatinib in Hospitalized COVID-19 Patients Published in Clinical Infectious Diseases
Published: 2021-09-01 (Crawled : 12:15) - biospace.com/
LLY | News | $731.81 -1.86% 1M
|
Health Technology
|
| O: 0.1%
H: 0.09%
C: -0.44%
RIGL | $1.13 -0.88% 260K
|
Health Technology
|
| O: -0.26%
H: 8.84%
C: 8.44%
covid disease phase 2 infectious disease trial
Insights on the Autoimmune Disease Diagnostics Global Market to 2026 - by Gender, Technology, Indication and Region
Published: 2021-08-24 (Crawled : 12:15) - prnewswire.com
TMO | News | $573.21 -0.24% 940K
|
Health Technology
|
| O: 0.31%
H: 0.0%
C: -0.69%
disease technology diagnostics diagnostic
AGTC Appoints Ophthalmology and Retinal Disease Specialist and Industry R&D Veteran Yehia Hashad, MD to its Board of Directors
Published: 2021-08-18 (Crawled : 12:15) - globenewswire.com
OTIC | $0.077
|
Health Technology
|
| O: 0.69%
H: 6.21%
C: -2.07%
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: -1.43%
H: 0.15%
C: -3.49%
disease retina
Rhythm Pharmaceuticals to Present at the 59th Annual ESPE MeetingCompany announces acceptance of seven abstracts with data from multiple clinical trials evaluating setmelanotide for rare genetic diseases of obesity
Published: 2021-08-12 (Crawled : 12:15) - biospace.com/
RYTM A | $40.08 0.2% 160K
|
Health Technology
|
| O: 0.0%
H: 3.41%
C: 3.12%
disease obesity genetic clinical trials trial setmelanotide rare
Harmony Biosciences Acquires Asset With Novel Mechanism Of Action For The Potential Treatment Of Narcolepsy And Other Rare Neurological Diseases
Published: 2021-08-09 (Crawled : 12:15) - prnewswire.com
HRMY | $29.05 0.69% 150K
|
Health Technology
|
| O: 0.99%
H: 3.32%
C: -2.33%
disease treatment neurological potential narcolepsy rare
Gainers vs Losers
| 54% | 46% |
Top 10 Gainers
CSSE 4 | $0.3499 129.74% 150M
|
Consumer Services
CZOO | $11.04 121.24% 9.6M
|
BOF | $1.88 60.68% 98M
|
AMST | $3.2 60.0% 63M
|
Technology Services
LICN | $0.8592 53.43% 13M
|
WIMI | $1.05 44.75% 13M
|
Technology Services
MULN | News | $3.675 34.62% 11M
|
Information
RILY | $28.605 31.7% 9.9M
|
Finance
RBBN 4 | $3.305 28.6% 1.9M
|
Electronic Technology
RCAT | $1.53 27.5% 2.9M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.